Cognex (NASDAQ:CGNX) Price Target Raised to $84.00 at Cantor Fitzgerald

Cognex (NASDAQ:CGNX) had its target price boosted by investment analysts at Cantor Fitzgerald from $76.00 to $84.00 in a report released on Friday,Benzinga reports. The firm currently has an “overweight” rating on the scientific and technical instruments company’s stock. Cantor Fitzgerald’s price target points to a potential upside of 24.67% from the company’s current price.

A number of other research firms have also recently commented on CGNX. Stephens boosted their price target on Cognex from $65.00 to $75.00 and gave the stock an “overweight” rating in a report on Thursday, May 7th. DA Davidson set a $62.00 price objective on Cognex and gave the company a “neutral” rating in a research note on Thursday, May 14th. Sanford C. Bernstein reaffirmed an “outperform” rating and issued a $75.00 price objective on shares of Cognex in a research note on Thursday, May 7th. Seaport Research Partners set a $75.00 target price on Cognex in a research report on Tuesday, May 26th. Finally, UBS Group set a $75.00 target price on Cognex in a research note on Tuesday, May 26th. Two research analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat.com, Cognex presently has a consensus rating of “Moderate Buy” and an average price target of $73.92.

Cognex Price Performance

Shares of NASDAQ:CGNX opened at $67.38 on Friday. The company’s 50 day simple moving average is $64.99 and its 200 day simple moving average is $57.09. The stock has a market capitalization of $11.21 billion, a price-to-earnings ratio of 65.42 and a beta of 1.49. Cognex has a 1 year low of $34.60 and a 1 year high of $72.88.

Cognex (NASDAQ:CGNX) last announced its quarterly earnings data on Wednesday, August 5th. The scientific and technical instruments company reported $0.45 EPS for the quarter, beating the consensus estimate of $0.42 by $0.03. Cognex had a net margin of 16.05% and a return on equity of 13.82%. The business had revenue of $291.26 million during the quarter, compared to the consensus estimate of $292.10 million. During the same period in the previous year, the business earned $0.25 earnings per share. The company’s revenue was up 16.9% on a year-over-year basis. Cognex has set its FY 2026 guidance at 1.640-1.680 EPS and its Q3 2026 guidance at 0.500-0.540 EPS. As a group, analysts anticipate that Cognex will post 1.48 EPS for the current fiscal year.

Insider Activity

In other Cognex news, insider Mark Fennell sold 64,873 shares of the company’s stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $67.05, for a total value of $4,349,734.65. Following the completion of the transaction, the insider owned 11,263 shares of the company’s stock, valued at $755,184.15. This represents a 85.21% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, VP Laura Ann Macdonald sold 98,122 shares of the company’s stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $66.80, for a total value of $6,554,549.60. Following the completion of the transaction, the vice president directly owned 5,258 shares of the company’s stock, valued at approximately $351,234.40. The trade was a 94.91% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 224,847 shares of company stock worth $14,975,098. Insiders own 1.70% of the company’s stock.

Institutional Trading of Cognex

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new position in shares of Cognex in the second quarter valued at approximately $26,000. Elevation Wealth Partners LLC boosted its position in Cognex by 635.4% during the 2nd quarter. Elevation Wealth Partners LLC now owns 478 shares of the scientific and technical instruments company’s stock worth $35,000 after buying an additional 413 shares during the period. FNY Investment Advisers LLC acquired a new stake in Cognex during the 2nd quarter worth approximately $45,000. Cassaday & Co Wealth Management LLC bought a new stake in Cognex during the 1st quarter worth approximately $36,000. Finally, CIBC Private Wealth Group LLC grew its holdings in Cognex by 74.8% during the 3rd quarter. CIBC Private Wealth Group LLC now owns 764 shares of the scientific and technical instruments company’s stock worth $35,000 after acquiring an additional 327 shares during the last quarter. 88.12% of the stock is currently owned by institutional investors.

Cognex Company Profile

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.